What's new

Human medicines European public assessment report (EPAR): Bylvay, odevixibat, Date of authorisation: 16/07/2021, Revision: 7, Status: Authorised

Human medicines European public assessment report (EPAR): Bylvay, odevixibat, Date of authorisation: 16/07/2021, Revision: 7, Status: Authorised

Apr 3, 2025 - 10:44
 0
Human medicines European public assessment report (EPAR): Bylvay, odevixibat, Date of authorisation: 16/07/2021, Revision: 7, Status: Authorised
Human medicines European public assessment report (EPAR): Bylvay, odevixibat, Date of authorisation: 16/07/2021, Revision: 7, Status: Authorised
Read More

Tags:

Previous Article

Boehringer commits $31M to ADC R&D via new Swiss facility for NBE Therapeutics

Next Article

First look: Matalan launches collection with Little Mistress and Vicki Pattinson

Related Posts

Human medicines European public assessment report (EPAR): Nimvastid, rivastigmine, Date of authorisation: 11/05/2009, Revision: 12, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 26, 2025  0

Human medicines European public assessment report (EPAR): Fymskina, ustekinumab, Date of authorisation: 25/09/2024, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 19, 2025  0

Human medicines European public assessment report (EPAR): Mirvaso, brimonidine, Date of authorisation: 20/02/2014, Revision: 14, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 4, 2025  0